Aeglea BioTherapeutics In... (AGLE)
NASDAQ: AGLE
· Real-Time Price · USD
12.01
0.75 (6.66%)
At close: Nov 27, 2023, 10:00 PM
Aeglea BioTherapeutics Fail-to-Deliver
Total FTD Shares
100
Below Average
FTD / Avg. Volume
0.17%
Low Impact
1-Year Change
n/a
FTD Chart
As of Nov 28, 2023,
Aeglea BioTherapeutics Inc. has
100
shares failed to deliver, representing 0.17%
of the average daily volume of
59,537
shares. Over the past year, the monthly average FTD is
18,247
shares, with the current level 99% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Nov 28, 2023 | 14.5 | 100 | -2.91% |
| Oct 31, 2023 | 11.64 | 103 | -96.06% |
| Sep 25, 2023 | 11.63 | 2.61K | +1.08% |
| Aug 11, 2023 | 12.5 | 2.58K | -95.93% |
| Jul 31, 2023 | 14.13 | 63.53K | +30.35% |
| Jun 30, 2023 | 11.28 | 48.74K | +130.49% |
| May 31, 2023 | 3.25 | 21.15K | -20.58% |
| Apr 28, 2023 | 4.22 | 26.63K | +45028.81% |
| Mar 10, 2023 | 9.5 | 59 | -99.39% |
| Feb 24, 2023 | 9.8 | 9.71K | +653.45% |
| Jan 27, 2023 | 12.75 | 1.29K | n/a |